Alternate antidepressant not effective for Alzheimer’s agitation, trial finds

Up to 60% of people with Alzheimer’s disease experience agitation, a symptom that can be a significant burden for caregivers. Nondrug treatments are recommended as first-line interventions. Citalopram, a selective serotonin reuptake inhibitor (SSRI) commonly prescribed for anxiety and depression, has shown promise for treating Alzheimer’s-induced agitation in patients whose symptoms don’t respond to other therapies.

Trade tariffs on Canadian pharmaceuticals expected to increase costs in the US and strain drug supply chains

Up to $3 billion in pharmaceuticals currently used in the United States (U.S.) depend on Canadian manufacturing, according to new research findings from the University of Toronto. Applying 25% trade tariffs to these pharmaceuticals could add $750 million in cost to the U.S. market and has the potential to significantly disrupt drug supply over the long term.

Break the sedentary cycle: National Walking Day can kickstart healthier routines

Sedentary behavior has become a national health crisis, with 1 in 4 U.S. adults sitting for more than eight hours a day, increasing their risk for heart disease, stroke, and mental health challenges, according to the Centers for Disease Control and Prevention. To help people move more, the American Heart Association, a global force changing the future of health of all, invites communities nationwide to walk together on Wednesday, April 2.